share_log

特一药业:2023年度独立董事述职报告(李桂生)

Teyi Pharmaceutical: 2023 Independent Director Debriefing Report (Li Guisheng)

Sensex a share ·  Mar 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more